Fundación para la Investigación Biosanitaria del Principado de Asturias
13
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.4% vs industry average
23%
3 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Evaluation of a Multi-Layered Digital Phenotyping, Digital Safety Plan, and Pharmacogenomic Intervention for Suicide Prevention in Adults With Depression
Role: collaborator
Digital Patient-Reported Assessment in Older Adults With Acute Leukemia
Role: lead
A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia (FOVOCIP)
Role: lead
Early Transcatheter Mitral Valve Repair After Myocardial Infarction
Role: lead
Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS
Role: lead
Personalized Medicine in Patients With Infective Endocarditis
Role: lead
Precision Medicine for Post-Intensive Care Syndrome (PreMed4PICS)
Role: lead
A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia
Role: lead
Restenosis in Coronary Stents And Cutaneous HEaLing
Role: lead
Lung Ultrasound Score and Pediatric Intensive Care Outcomes (LUS-PICO)
Role: lead
Ultra Protective Ventilation During Venoarterial Extracorporeal Membrane Oxygenation (UPV-ECMO)
Role: lead
Effect of Vitamin D on Morbidity and Mortality of the COVID-19
Role: lead
Learning Curves for Airtraq Versus King Vision Laryngoscopes
Role: lead
All 13 trials loaded